Rivastigmine Tartrate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers, 18 USDMF, 12 CEP/COS, 15 EU WC, 18 KDMF, 6 NDC API, 24 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

9 Suppliers

9 Suppliers

DOSSIERs // Finished Dosage Forms

120 Dossiers, 46 FDA Orange Book, 40 Europe, 29 Canada, 5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 17 Roquette, 15 Kerry, 10 Corel Pharma Chem, 10 Microlex e.U, 8 Seppic, 8 Sigachi Industries, 8 BASF, 6 Lonza Capsugel, 6 Gangwal Healthcare, 6 Gangwal Chemicals, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 Ideal Cures Pvt Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 ACG Worldwide, 4 SPI Pharma, 3 Kima Chemical, 2 Vasa Pharmachem, 2 Qualicaps, 2 Ingredion Pharma Solutions, 2 Prachin Chemical, 2 DFE Pharma, 2 The Dow Chemical Company, 1 Nanjing Well Pharmaceutical, 1 Pharmatrans-Sanaq, 1 Finar, 1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives, 35 Fillers, Diluents & Binders, 21 Controlled & Modified Release, 18 Direct Compression, 15 Lubricants & Glidants, 14 Thickeners and Stabilizers, 11 Film Formers & Plasticizers, 11 Granulation, 10 Disintegrants & Superdisintegrants, 9 Empty Capsules, 9 Taste Masking, 8 Co-Processed Excipients, 6 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Topical, 3 Emulsifying Agents, 2 Coloring Agents, 2 Solubilizers, 2 Rheology Modifiers, 1 Parenteral

GLOBAL SALES INFORMATION

18 US Medicaid Prescriptions, 12 Finished Drug Prices

MARKET PLACE

3 APIs

3 APIs

PATENTS

11 Health Canada Patents

11 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 2 Others

DIGITAL CONTENT

7 News

7 News

Pharmacy pricing data of Rivastigmine Tartrate obtained from U.S. Medicaid's National Average Drug Acquisition Cost

Rivastigmine Tartrate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

38 Suppliers

18 USDMF

12 CEP/COS

15 EU WC

18 KDMF

6 NDC API

24 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

9 Suppliers

DOSSIERs // Finished Dosage Forms

120 Dossiers

46 FDA Orange Book

40 Europe

29 Canada

5 Listed Dossiers

DRUG PRODUCT COMPOSITION

CAPSULE;ORAL - EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

17 Roquette

15 Kerry

10 Corel Pharma Chem

10 Microlex e.U

8 Seppic

8 Sigachi Industries

8 BASF

6 Lonza Capsugel

6 Gangwal Healthcare

6 Gangwal Chemicals

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 Ideal Cures Pvt Ltd

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 ACG Worldwide

4 SPI Pharma

3 Kima Chemical

2 Vasa Pharmachem

2 Qualicaps

2 Ingredion Pharma Solutions

2 Prachin Chemical

2 DFE Pharma

2 The Dow Chemical Company

1 Nanjing Well Pharmaceutical

1 Pharmatrans-Sanaq

1 Finar

1 Qianhao Chemical (Hebei) Co., Ltd

EXCIPIENTS BY APPLICATIONS

46 Coating Systems & Additives

35 Fillers, Diluents & Binders

21 Controlled & Modified Release

18 Direct Compression

15 Lubricants & Glidants

14 Thickeners and Stabilizers

11 Film Formers & Plasticizers

11 Granulation

10 Disintegrants & Superdisintegrants

9 Empty Capsules

9 Taste Masking

8 Co-Processed Excipients

6 Chewable & Orodispersible Aids

4 Vegetarian Capsules

4 API Stability Enhancers

4 Topical

3 Emulsifying Agents

2 Coloring Agents

2 Solubilizers

2 Rheology Modifiers

CAPSULE;ORAL - EQ 1.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 3MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 4.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 6MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

EQ 1.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons